Women with endometriosis often have undiagnosed iron deficiency: Study

A recent multi-center study conducted at 2 tertiary care hospitals found that over half of women with endometriosis with undiagnosed iron deficiency by raising concerns about the impact of this condition on overall health and quality of life. The findings were published in the International Journal of Gynecology & Obstetrics.

This research included a total of 251 non-pregnant women aged 18 to 50 who were either clinically or surgically diagnosed with symptomatic endometriosis. The participants underwent blood tests, including complete blood count, ferritin levels, and transferrin saturation. This study also completed comprehensive surveys detailing their medical and surgical history, demographics, and specific symptoms of iron deficiency and endometriosis.

The outcomes of this study found 53.4% of participants to have iron deficiency, and 13.5% had progressed to iron deficiency anemia. Many women with iron deficiency reported experiencing heavy menstrual bleeding (HMB), a common symptom of endometriosis. This study found that HMB was not always a definitive indicator of iron deficiency. While 49.6% of women with iron deficiency reported HMB, 47% of women with iron deficiency did not experience HMB at all.

The findings emphasized the importance of transferrin saturation as a diagnostic marker. In cases where ferritin levels appeared normal (≥30 ng/mL), transferrin saturation was instrumental in diagnosing iron deficiency by accounting for 35.7% of such cases. This underlined the necessity of comprehensive screening beyond routine ferritin tests for identifying iron deficiency in this population.

The study also highlighted the broader impact of iron deficiency on well-being. The patients with iron deficiency had significantly lower scores on the Functional Assessment of Chronic Illness Therapy Fatigue Subscale which indicated more severe fatigue when compared to the ones without iron deficiency. Fatigue is a particularly debilitating symptom for women with endometriosis, affecting their daily functioning and quality of life.

This research suggests that undiagnosed iron deficiency is highly prevalent among women with endometriosis, even in the absence of classic symptoms like HMB. Further, the study calls for future research to assess the potential benefits of iron supplementation in managing symptoms and improving quality of life for these patients. This study highlights on an often-overlooked area of endometriosis care and reminds the need for targeted interventions to address iron deficiency in affected women.

Reference:

Goldberg, H. R., McCaffrey, C., Solnik, J., Lemos, N., Sobel, M., Kives, S., Malinowski, A. K., Shehata, N., Matelski, J., Szczech, K., & Murji, A. (2024). High prevalence of undiagnosed iron deficiency in endometriosis patients: A cross‐sectional study. In International Journal of Gynecology & Obstetrics. Wiley. https://doi.org/10.1002/ijgo.15994

Powered by WPeMatico

Higher Prognostic Nutritional Index linked to low prevalence of RA and subsequent mortality, finds study

Higher Prognostic Nutritional Index linked to the low prevalence of Rheumatoid arthritis and subsequent mortality finds a study published in the BMC Public Health.

The prognostic nutritional index (PNI) is a comprehensive measure of individual immune and nutritional status. This study aimed to evaluate the role of PNI in the presence and mortality of rheumatoid arthritis (RA). This study used data of participants aged ≥ 40 years from the National Health and Nutrition Examination Survey (NHANES) 2003–2018. PNI was calculated using serum albumin and lymphocyte count. The relationship between PNI and the prevalence of Rheumatoid arthritis and mortality among Rheumatoid arthritis patients was assessed using logistic and Cox regression models. Nonlinear associations were explored using restricted cubic splines (RCS). Results: Of 18,245 participants (mean 55.4 years, 49% female), 1901 had Rheumatoid arthritis, among whom (480/1899, 25%) died during a median follow-up period of 84 months. PNI was inversely associated with the likelihood of having Rheumatoid arthritis (odds ratio = 0.97, 95% confidence interval [CI]: 0.95–0.98). Compared to participants whose PNI was in the lowest quartile, those in other quartiles had a reduced likelihood of having Rheumatoid arthritis by 21-38% (Ptrend <0.01). Cox regression analysis revealed an inverse association between PNI and all-cause mortality (hazard ratio = 0.95, 95%CI: 0.91–0.99). An L-shaped association was observed between PNI and the presence and all-cause mortality of Rheumatoid arthritis, with turning points occurring around the mean value of PNI. The presence and all-cause mortality of Rheumatoid arthritis was significantly reduced before the turning points of PNI and plateaued afterwards. In middle-aged and older adults, there is an inverse association between PNI and the presence and all-cause mortality of Rheumatoid arthritis.

Reference:

Wang, J., Zhu, R., Fang, H. et al. Association of prognostic nutritional index with the presence and all-cause mortality of rheumatoid arthritis: the National Health and Nutrition Examination Survey 2003–2018. BMC Public Health 24, 3281 (2024). https://doi.org/10.1186/s12889-024-20795-0

Keywords:

Higher, Prognostic, Nutritional, Index, linked, low, prevalence, RA, subsequent, mortality, find, study, BMC Public Health, Wang, J., Zhu, R., Fang, H, All-cause mortality, Prognostic nutritional index, Rheumatoid arthritis

Powered by WPeMatico

BMD may differ on paretic and nonparetic sides in stroke patients with issues of falls and balance: Study

A new study published in the Journal of Physical Medicine and Rehabilitation found that in stroke patients with previous instances of falls and balance issues, bone mineral density (BMD) may vary on the paretic and nonparetic sides. 90% of stroke survivors have some functional difficulties, such as muscular weakness, discomfort, stiffness, cognitive dysfunction, poor balance, and frequent falls. Stroke is one of the primary causes of long-term disability. Reduced exercise and sedentary lifestyles brought on by these impairments may result in subsequent reductions in function and disability status.

It is generally recognized that stroke patients have a higher risk of fractures from unintentional falls and post-stroke osteoporosis, especially of the hip. Bone mineral density (BMD) measures are frequently taken unilaterally, and only a small number of the most recent stroke recommendations advise doing so throughout follow-up in this cohort. Tugba Atan and colleagues undertook this study to compare the femoral hip BMD of stroke patients who fall vs those who do not, as well as to evaluate variations in balance, mobility, and fear of falling, and to investigate differences between paretic and nonparetic sides within each group.

The inpatient stroke rehabilitation unit of a tertiary university hospital was the subject of this cross-sectional investigation. The primary subjects of the study were hospitalized stroke patients with unilateral hemiplegia. The femoral neck BMD measurement was the main result. BMD was measured by dual-energy x-ray absorptiometry. Functional ambulation classification (FAC), timed up-and-go test (TUGT), Berg balance scale (BBS), and falls efficacy scale-international (FES-I) were examples of secondary outcomes.

A total of 44 patients were enrolled. 50% of the volunteers, or 22, reported falling. The BMD and T-scores of the paretic, nonparetic femoral neck, and lumbar spine did not differ statistically significantly between fallers and non-fallers. Among the fallers, the BBS was considerably lower (p =.033, 95% CI 0.17-19.05). Statistically, the fallers had a considerably greater FES-I.

In the non-fallers (n = 22), there was no significant difference in the BMD and T-scores of the femoral neck between the paretic and nonparetic limbs (p =.908, 95% CI -0.03-0.03; p =.886, 95% CI -0.27-0.24), but there was a difference in the fallers. Overall, this study highlights that hip BMD can vary between paretic and nonparetic sides, particularly in stroke patients who have experienced falls and balance issues in the past. 

Reference:

Atan, T., Ekinci, U., Uran San, A., Demir, Y., Guzelkucuk, U., Kesikburun, S., Uyar Koylu, S., & Tan, A. K. (2024). The relationship between falls and hip bone mineral density of paretic and nonparetic limbs after stroke. In PM&R. Wiley. https://doi.org/10.1002/pmrj.13290

Powered by WPeMatico

Vitamin D deficiency linked to higher foveal retinal thickness and decreased vascular density levels, suggests study

A new study published in the journal of Eye found that the amount of vitamin D and foveal retinal thickness (FRT) in children is negatively correlated in studies employing optical coherence tomography angiography (OCTA). The immune system, inflammation, cell division and proliferation, apoptosis, angiogenesis, and gene expression are just a few of the many ways that vitamin D supports human health.

Based on the Endocrine Society’s position, blood vitamin D levels should be between 40 and 60 ng/mL. For babies under one year old, the daily intake should be 400 to 1000 International Units (IU). For children and adolescents aged 1 to 18, it should be 600 to 1000 IU, and for adults, it should be 1500 to 2000 IU. Thereby, to assess the retinal and optic nerve head microvasculature in children with vitamin D insufficiency using OCTA, Bengi Ece Kurtul and his team carried out this investigation.

A total of  74 eyes of 37 children with vitamin D insufficiency (Group I) and the 64 eyes of 32 healthy children (Group II) were included for examination by OCTA in this prospective, cross-sectional investigation. Analysis and comparison between the groups were conducted using foveal retinal thickness (FRT), vascular density (VD) in various retinal slices, peripapillary retinal nerve fiber layer (RNFL) thickness, and optic disc thickness.

The mean central corneal thickness levels, mean intraocular pressures, mean ages, and gender of the groups were comparable. Vitamin D levels in the venous blood samples of participants were statistically significant (P < 0.001), with mean levels in Group I being 11.42 ± 4.94 ng/mL and Group II being 26.03 ± 11.08 ng/mL.

The groups’ optic disc capillary densities did not differ significantly from one another. However, Group I displayed considerably lower superficial total, parafoveal, and perifoveal VD values and significantly greater FRT values as compared to Group II. In Group I, the vitamin D levels and FRT values had a substantially negative connection (r = -0.439, P = 0.001).

Overall, higher FRT readings and lower superficial VD levels appear to be linked to vitamin D insufficiency. When compared to children with normal vitamin D levels (26.03 ng/mL), the ones with low levels (11.42 ng/mL) had thicker foveal retinas and less vascular density in the retina, particularly in the parafoveal and perifoveal areas. Vitamin D insufficiency in pediatric patients may have an impact on retinal microvascular architecture.

Source:

Kurtul, B. E., Sipal, C., & El, C. (2024). Ocular haemodynamics in children with vitamin D deficiency. In Eye. Springer Science and Business Media LLC. https://doi.org/10.1038/s41433-024-03528-w

Powered by WPeMatico

NBE To End DNB PDCET 2024 Round 2 Choice Filling Tomorrow

New Delhi- The National Board of Examinations in Medical Sciences (NBEMS) has finally announced the DNB PDCET 2024 counselling dates on its official website. As per the schedule, the DNB PDCET Round 2 choice filling and locking process has already started from December 16, 2024, in online mode. The DNB PDCET Counselling 2024 choice filling and locking link is active on the official website of NBE Counselling.

Also, candidates who have participated in the said counselling should note that no fresh registration process will be conducted for Round 2 DNB PDCET Counselling 2024. Therefore, students who have completed Round 1 registration but did not get their preferred seat during the Round 1 counselling process can complete the preference filling for Round 2 by tomorrow i.e. December 18, 2024.

Students are advised not to wait for the DNB PDCET Choice Filling and Locking last date 2024 to avoid unforeseen circumstances.

DNB PDCT 2024 COUNSELLING SCHEDULE

S.NO

PARTICULARS

DATES

1

Filling up options/ choices of available seats.

16 to 18 December 2024

2

Result of Allotment.

20 December 2024

3

Payment of First-Year Course Fee.

20 to 24 December 2024

4

Physical Joining at the allotted hospital.

20 to 24 December 2024

Meanwhile, as per the NBE DNB PDCET 2024 Information Bulletin, candidates who have secured a merit position in the DNB Post Diploma Centralized Entrance Test (DNB-PDCET) 2024 conducted by NBEMS and fulfil the eligibility criteria for admission to DNB (Post Diploma) courses (2024 admission session) at various NBEMS accredited Medical Colleges/ Institutions/ Hospitals in India shall participate in the counselling for allocation of seats purely on merit cum choice basis.

Centralized merit-based counselling shall be conducted by the NBEMS for allotment of Post Diploma DNB seats at NBEMS-accredited Institutions/hospitals/medical colleges in order of speciality-specific merit. Candidate shall be able to opt for the NBEMS accredited institution/hospital/medical college of their choice as per availability at their merit.

Powered by WPeMatico

Eli Lilly and Company gets CDSCO panel nod to import, market Tirzepatide Multiple Dose Pen

New Delhi: The pharmaceutical major Eli Lilly and Company (India) has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to import and market of Tirzepatide Multiple Dose Pen (additional of new presentation—KwkPen) 2.5 mg/0.6 ml, 5 mg/0.6 ml, 7.5 mg/0.6 ml, 10.0 mg/0.6 ml, 12.5 mg/0.6 ml, and 15.0 mg/0.6 ml in India, subject to the condition that the firm should conduct a Phase-IV clinical trial.

This came after Eli Lilly and Company (India) presented the justification for Cmax values at a 90% confidence interval based on clinical data and intended use.

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, used for the treatment of type II diabetes in adults as an adjunct to diet and exercise.

The exact mechanism of action of tirzepatide has not been fully elucidated; however, dual agonism at GIP and GLP-1R may contribute to the glycemic and weight control effects of the drug. Studies demonstrated that co-administration of GIP and a GLP-1R agonist significantly increased insulin response and suppressed glucagon secretion compared to separate administration of either hormone alone. Tirzepatide binds to GIP and GLP-1R with high affinity. Tirzepatide potently activates the GLP-1R signalling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.

At the earlier SEC meeting, the firm presented their proposal for grant of permission to import and market Tirzepatide multiple dose pens (addition of new presentation, Kikpen): 2.5 mg/0.6 ml, 5.0 mg/0.6 ml, 7.5 mg/0.6 ml, 10.0 mg/0.6 ml, 12.5 mg/0.6 ml, and 15.0 mg/0.6 ml, along with a bioequivalence study report of Tirzepatide subcutaneously by a fixed-dose multi-use prefilled pen versus a single-dose pen in healthy participants conducted in the USA and with a request for waiver of the Phase-III clinical trial before the committee.

Responding to the above, the expert panel at the earlier meeting for endocrinology and metabolism opined that the firm should submit interim efficacy data of the Phase IV clinical trial of already approved single-dose prefilled pen formulations in the Indian population along with global safety and efficacy data on multidose prefilled pen products with preservatives to CDSCO for further review by the committee.

Now, in continuation, at the recent SEC meeting for endocrinology and metabolism held on 11.12.2024, the drug major Eli Lilly and Company (India) presented the justification for Cmax values at a 90% confidence interval based on clinical data and intended use.

In addition to the above, the firm has informed that Tirzepatide Multiple Dose Pen (KwkPen) is already approved in UK, Europe, Canada, etc.

After detailed deliberation, the committee recommended the grant of permission for the import and marketing of Tirzepatide Multiple Dose Pens (additional to the new presentation—KwkPen): 2.5 mg/0.6 mL, 5 mg/0.6 mL, 7.5 mg/0.6 mL, 10.0 mg/0.6 mL, 12.5 mg/0.6 mL, and 15.0 mg/0.6 mL in India, with the condition that the firm should conduct a Phase-IV clinical trial.

Furthermore, the committee stated that the firm should submit the Phase IV clinical trial protocol within 3 months from the date of approval of the drug to CDSCO for further review by the committee.

Powered by WPeMatico

Study finds lower rates of death from Alzheimer’s disease among taxi and ambulance drivers

A new study raises the possibility that jobs that require frequent spatial processing—such as figuring out a taxi route or the best way to navigate to a hospital—could lead to lower rates of death from Alzheimer’s disease. Researchers from Mass General Brigham investigated this possibility by using national data on the occupations of people who had died to evaluate risk of death from Alzheimer’s disease across 443 professions.

Powered by WPeMatico

Coaching trainees just before a procedure could improve patient safety, say researchers

Giving inexperienced clinicians a quick coaching session with an expert just before they carry out a procedure boosts their success rate and could improve patient safety, finds a study in the Christmas issue of The BMJ.

Powered by WPeMatico

Disney princesses face hidden health risks, warn experts

Although Disney princesses seem to live happily ever after, they face serious real world health hazards, warn experts in the Christmas issue of The BMJ.

Powered by WPeMatico

Researchers examine the legal and ethical aspects of AI in radiology

Bart Custers and Eduard Fosch-Villaronga from eLaw–Center for Law and Digital Technologies have contributed a chapter to the volume “AI Implementation in Radiology: Challenges and Opportunities in Clinical Practice.”

Powered by WPeMatico